Natixis Advisors LLC Sells 101,113 Shares of Azenta, Inc. (NASDAQ:AZTA)

Natixis Advisors LLC reduced its holdings in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) by 27.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 273,000 shares of the company's stock after selling 101,113 shares during the quarter. Natixis Advisors LLC owned approximately 0.60% of Azenta worth $9,457,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in AZTA. Lord Abbett & CO. LLC bought a new position in shares of Azenta during the 4th quarter worth approximately $47,350,000. Norges Bank bought a new position in shares of Azenta during the 4th quarter worth approximately $25,403,000. Marshall Wace LLP bought a new position in shares of Azenta during the 4th quarter worth approximately $20,469,000. Conestoga Capital Advisors LLC boosted its holdings in shares of Azenta by 21.4% in the 1st quarter. Conestoga Capital Advisors LLC now owns 1,915,556 shares of the company's stock valued at $66,355,000 after buying an additional 337,675 shares during the last quarter. Finally, Federated Hermes Inc. boosted its holdings in shares of Azenta by 65.9% in the 4th quarter. Federated Hermes Inc. now owns 762,189 shares of the company's stock valued at $38,109,000 after buying an additional 302,786 shares during the last quarter. 99.08% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts have recently commented on AZTA shares. Evercore ISI increased their price objective on Azenta from $29.00 to $35.00 and gave the company an "in-line" rating in a report on Tuesday, July 8th. Needham & Company LLC cut their price objective on Azenta from $59.00 to $40.00 and set a "buy" rating for the company in a report on Wednesday, May 7th. Finally, Stephens started coverage on Azenta in a report on Tuesday, July 22nd. They issued an "equal weight" rating and a $35.00 price objective for the company.

Azenta Price Performance

Shares of Azenta stock opened at $32.41 on Tuesday. The business has a fifty day simple moving average of $31.03 and a two-hundred day simple moving average of $34.91. Azenta, Inc. has a 1 year low of $23.91 and a 1 year high of $60.60. The company has a market capitalization of $1.48 billion, a price-to-earnings ratio of -23.32 and a beta of 1.59.

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, May 7th. The company reported $0.05 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.09 by ($0.04). Azenta had a negative net margin of 10.31% and a positive return on equity of 1.30%. During the same period last year, the company posted $0.06 EPS. The business's revenue for the quarter was up 5.1% compared to the same quarter last year. As a group, equities analysts anticipate that Azenta, Inc. will post 0.53 earnings per share for the current fiscal year.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Want to see what other hedge funds are holding AZTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Azenta, Inc. (NASDAQ:AZTA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.